Abion

Therapeutics for cancer and auto-immune diseases.

placeSeoul, Seoul, South Korea calendar_todayFounded 2007 groups33 employees language abionbio.com

Registered entities

Investor mix

10 investors on record; lead investors include Korea Investment Holdings.

Investor typeCountShare
Venture capital550%
Private equity220%
Bank & private debt110%
Other / undisclosed220%
Coming soon